Tower Research Capital LLC (Trc) Liquidia Corp Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Liquidia Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 769 shares of LQDA stock, worth $11,604. This represents 0.0% of its overall portfolio holdings.
Number of Shares
769
Previous 1,993
61.41%
Holding current value
$11,604
Previous $19,000
52.63%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding LQDA
# of Institutions
187Shares Held
44.6MCall Options Held
1.22MPut Options Held
1.09M-
Black Rock Inc. New York, NY4.24MShares$64 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.56MShares$53.7 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.29MShares$49.7 Million0.21% of portfolio
-
Findell Capital Management LLC New York, NY3.08MShares$46.5 Million14.82% of portfolio
-
Kynam Capital Management, LP Princeton, NJ2.27MShares$34.2 Million1.69% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $971M
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...